The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.

Rapid waning of anti-polysaccharide bactericidal Ab and vaccine effectiveness is observed following infant immunization with the serogroup C meningococcal (MenC) glycoconjugate vaccine. This is despite the demonstrable presence of immunological memory. Persistence of functional Ab, therefore, appear...

Full description

Bibliographic Details
Main Authors: Blanchard Rohner, G, Snape, MD, Kelly, D, John, T, Morant, A, Yu, L, Borkowski, A, Ceddia, F, Borrow, R, Siegrist, C, Pollard, A
Format: Journal article
Language:English
Published: 2008
_version_ 1797099039001411584
author Blanchard Rohner, G
Snape, MD
Kelly, D
John, T
Morant, A
Yu, L
Borkowski, A
Ceddia, F
Borrow, R
Siegrist, C
Pollard, A
author_facet Blanchard Rohner, G
Snape, MD
Kelly, D
John, T
Morant, A
Yu, L
Borkowski, A
Ceddia, F
Borrow, R
Siegrist, C
Pollard, A
author_sort Blanchard Rohner, G
collection OXFORD
description Rapid waning of anti-polysaccharide bactericidal Ab and vaccine effectiveness is observed following infant immunization with the serogroup C meningococcal (MenC) glycoconjugate vaccine. This is despite the demonstrable presence of immunological memory. Persistence of functional Ab, therefore, appears to be the key determinant of MenC conjugate vaccine effectiveness. Ab persistence is thought to depend in the short term on the survival of plasma cells generated during priming and in the longer term on the production of new Ab secreting cells from memory B cells. In this study, we found a strong association between the level of MenC-specific Ab and the frequency of memory B cells measured at 5 mo of age (1 mo after 3-dose primary immunization with MenC conjugate vaccine), and the persistence of functional Ab at one year of age. These findings suggest that these two parameters are good markers of B cell responses to priming and can be used as predictors of long term humoral immunity induced by glycoconjugate vaccines received in early infancy.
first_indexed 2024-03-07T05:18:01Z
format Journal article
id oxford-uuid:dde7890b-ef00-4ce8-86d2-1814a1273e6e
institution University of Oxford
language English
last_indexed 2024-03-07T05:18:01Z
publishDate 2008
record_format dspace
spelling oxford-uuid:dde7890b-ef00-4ce8-86d2-1814a1273e6e2022-03-27T09:28:16ZThe magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:dde7890b-ef00-4ce8-86d2-1814a1273e6eEnglishSymplectic Elements at Oxford2008Blanchard Rohner, GSnape, MDKelly, DJohn, TMorant, AYu, LBorkowski, ACeddia, FBorrow, RSiegrist, CPollard, ARapid waning of anti-polysaccharide bactericidal Ab and vaccine effectiveness is observed following infant immunization with the serogroup C meningococcal (MenC) glycoconjugate vaccine. This is despite the demonstrable presence of immunological memory. Persistence of functional Ab, therefore, appears to be the key determinant of MenC conjugate vaccine effectiveness. Ab persistence is thought to depend in the short term on the survival of plasma cells generated during priming and in the longer term on the production of new Ab secreting cells from memory B cells. In this study, we found a strong association between the level of MenC-specific Ab and the frequency of memory B cells measured at 5 mo of age (1 mo after 3-dose primary immunization with MenC conjugate vaccine), and the persistence of functional Ab at one year of age. These findings suggest that these two parameters are good markers of B cell responses to priming and can be used as predictors of long term humoral immunity induced by glycoconjugate vaccines received in early infancy.
spellingShingle Blanchard Rohner, G
Snape, MD
Kelly, D
John, T
Morant, A
Yu, L
Borkowski, A
Ceddia, F
Borrow, R
Siegrist, C
Pollard, A
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.
title The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.
title_full The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.
title_fullStr The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.
title_full_unstemmed The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.
title_short The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.
title_sort magnitude of the antibody and memory b cell responses during priming with a protein polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response
work_keys_str_mv AT blanchardrohnerg themagnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT snapemd themagnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT kellyd themagnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT johnt themagnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT moranta themagnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT yul themagnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT borkowskia themagnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT ceddiaf themagnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT borrowr themagnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT siegristc themagnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT pollarda themagnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT blanchardrohnerg magnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT snapemd magnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT kellyd magnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT johnt magnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT moranta magnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT yul magnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT borkowskia magnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT ceddiaf magnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT borrowr magnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT siegristc magnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse
AT pollarda magnitudeoftheantibodyandmemorybcellresponsesduringprimingwithaproteinpolysaccharideconjugatevaccineinhumaninfantsisassociatedwiththepersistenceofantibodyandtheintensityofboosterresponse